Multimorbidity in type 1 Gaucher disease patients under miglustat therapy

被引:0
|
作者
Engay, Blanca Medrano [1 ]
Roy, Ana [2 ]
Atutxa, Koldo [3 ]
Diaz-Morant, Vicente [4 ]
Garcia-Frade, Javier [5 ]
Hernandez-Martin, Roberto [6 ]
Luno, Elisa [7 ]
Noya, Soledad [8 ]
de la Serna, Javier [9 ]
Villalon, Lucia [10 ]
Giraldo, Pilar [11 ]
机构
[1] Inst Invest Sanitaria Aragon, Zaragoza, Spain
[2] Fdn Espanola Estudio & Terapeut Enfermedad Gauche, Zaragoza, Spain
[3] Hosp Galdakao, Bilbao, Spain
[4] Hosp Serrania Ronda, Ronda, Spain
[5] Hosp Rio Hortega, Valladolid, Spain
[6] Hosp Virgen de la Concha, Zamora, Spain
[7] Hosp Univ Cent Asturias, Oviedo, Spain
[8] Hosp Teresa Herrera, La Coruna, Spain
[9] Hosp Univ Doce Octubre, Madrid, Spain
[10] Hosp Alcorcon, Madrid, Spain
[11] Ciber Enfermedades Raras, Zaragoza, Spain
关键词
D O I
10.1016/j.ymgme.2017.12.245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
236
引用
收藏
页码:S93 / S94
页数:2
相关论文
共 50 条
  • [21] Combined therapy of imiglucerase and miglustat in Gaucher disease with severe bone complications
    Marie, Isabelle
    PRESSE MEDICALE, 2009, 38 : 2S68 - 2S70
  • [22] Short-term effect of oral treatment with miglustat in type 1 Gaucher disease.
    Giraldo, P
    Alonso, D
    Acedo, M
    Franco, R
    Barez, A
    Corrales, A
    Serrano, D
    Roldan, V
    Latre, P
    Alfonso, P
    Pocovi, M
    BLOOD, 2005, 106 (11) : 629A - 630A
  • [23] Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
    Giraldo, Pilar
    Andrade-Campos, Marcio
    Alfonso, Pilar
    Irun, Pilar
    Atutxa, Koldo
    Acedo, Antonio
    Barez, Abelardo
    Blanes, Margarita
    Diaz-Morant, Vicente
    Angeles Fernandez-Galan, Ma
    Franco, Rafael
    Gil-Cortes, Cristina
    Giner, Vicente
    Ibanez, Angela
    Latre, Paz
    Loyola, Ines
    Luno, Elisa
    Hernandez-Martin, Roberto
    Medrano-Engay, Blanca
    Puerta, Jose
    Roig, Inmaculada
    de la Serna, Javier
    Salamero, Olga
    Villalon, Lucia
    Pocovi, Miguel
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 173 - 179
  • [24] Two-year oral miglustat in Gaucher disease type III
    Schiffmann, Raphael
    Chris, Harris
    Catherine, DeVile
    Elin, Davis-Pope
    Ed, Fitzgibbon
    Roscoe, Brady
    Larry, Abel
    Pauline, Campbell
    Ashok, Vellodi
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S33 - S33
  • [25] TEN YEARS OF EXPERIENCE WITH MIGLUSTAT IN TREATMENT OF TYPE 1 GAUCHER DISEASE: THE SPANISH ZAGAL PROJECT
    Giraldo, P.
    Andrade, M.
    Alfonso, P.
    Irun, P.
    Atucha, L.
    Acedo, A.
    Diaz-Morant, V.
    Barez, A.
    Fernandez-Galan, M.
    Franco, R.
    Giner, V.
    Loyola, I.
    Luno, E.
    de la Serna, J.
    Villalon, L.
    Salamero, O.
    Pocovi, M.
    HAEMATOLOGICA, 2014, 99 : 764 - 764
  • [26] Randomized, Controlled Trial of Miglustat in Gaucher's Disease Type 3
    Schiffmann, Raphael
    Fitzgibbon, Edmond J.
    Harris, Chris
    DeVile, Catherine
    Davies, Elin H.
    Abel, Larry
    van Schaik, Ivo N.
    Benko, William
    Timmons, Margaret
    Ries, Markus
    Vellodi, Ashok
    ANNALS OF NEUROLOGY, 2008, 64 (05) : 514 - 522
  • [27] Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study
    Kuter, David J.
    Mehta, Atul
    Hollak, Carla
    Giraldo, Pilar
    Hughes, Derralynn
    Belmatoug, Nadia
    Brand, Monika
    Muller, Audrey
    Schaaf, Berthold
    Giorgino, Ruben
    Zimran, Ari
    BLOOD, 2011, 118 (21) : 1385 - 1385
  • [28] Enzyme replacement therapy in romanian patients with type 1 Gaucher disease
    Sido, P. Grigorescu
    Drugan, C.
    Cret, V.
    Al-Kzouz, C.
    Denes, C.
    Zimmermann, A.
    Coldea, C.
    CLINICAL THERAPEUTICS, 2007, 29 : S118 - S118
  • [29] MIGLUSTAT THERAPY IN TYPE 1 GAUCHER DISEASE: LONG-TERM TREATMENT EXPERIENCE FROM A MULTICENTER, RETROSPECTIVE COHORT STUDY
    Hollak, C. E. M.
    Kuter, D.
    Giraldo, P.
    Hughes, D.
    Belmatoug, N.
    Brand, M.
    Muller, A.
    Schaaf, B.
    Giorgino, R.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S97 - S97
  • [30] Substrate Reduction Therapy With Miglustat In Type 1 Gaucher Disease In Spain. Nine Years Outcomes Update On ZAGAL Study
    Giraldo, Pilar
    Andrade, Marcio M., Sr.
    Medrano, Blanca
    Alfonso, Pilar
    Irun, Pilar
    Atutxa, Koldo
    Fernandez-Galan, Angeles
    Barez, Abelardo
    Franco, Rafael
    Roig, Inmaculada
    Giner, Vicente
    Villalon, Lucia
    Martinez-Estefano, Elisa
    Luno, Elisa
    Loyola, Ines
    Salamero, Olga
    de la Serna, Javier
    Pocovi, Miguel
    BLOOD, 2013, 122 (21)